Is the US prepared to deal with another pandemic or widespread health crisis?
I will assess US pandemic preparedness by reviewing recent official reports, expert analyses, and key readiness indicators from public health agencies and independent evaluations.No, the United States is not fully prepared for another pandemic or widespread health crisis, though it has made meaningful improvements in some areas since COVID-19 while facing persistent gaps and recent setbacks that leave it vulnerable.[1][2]
Assessments from bipartisan commissions, the Government Accountability Office (GAO), Trust for America’s Health (TFAH), the World Health Organization (WHO) Joint External Evaluation (JEE), CDC testimony, and independent experts consistently show a mixed picture: enhanced stockpiles, surveillance tools, and medical countermeasure (MCM) capabilities exist alongside chronic underinvestment, fragmented leadership/coordination, workforce shortages, supply-chain risks, eroded public trust, and variable state/local readiness. Recent policy and funding disruptions (2025–2026) have further weakened capacity.[3][4][5]
Key Improvements Post-COVID
The 2024 WHO JEE of U.S. International Health Regulations capacities noted developed-to-demonstrated levels in many technical areas and praised transparency and global contributions, while issuing recommendations for further strengthening.[5]
Persistent and Growing Gaps
Bottom Line and Outlook
The U.S. has stronger baseline tools (stockpiles, digital surveillance, MCM pipelines, some coordination mechanisms) than in early 2020 and ranks relatively high historically on indices like the Global Health Security Index—yet COVID exposed that rankings do not guarantee effective real-world performance amid politics, trust deficits, and execution failures.[18]
Experts and reports (Bipartisan Commission, GAO, TFAH, Stimson, NEJM commentaries) conclude the country is underprepared for a severe novel respiratory pathogen, bioterror event, or concurrent crises. H5N1 avian influenza spillover concerns have repeatedly tested (and sometimes revealed shortcomings in) response agility. A major event would still strain hospitals, supply chains, and governance, with uneven impacts by state and population group.[18][2]
Preparedness is not binary—it is a continuum requiring sustained, bipartisan funding; clear authorities and exercises; resilient supply chains and domestic production; a robust, trusted workforce; modern data systems; community engagement/equity focus; and global cooperation. Without reversing recent erosions and closing long-standing gaps (as urged in the 2024 Blueprint’s dozens of recommendations), the U.S. risks repeating or exceeding COVID-scale impacts. Progress is possible and has occurred before; the question is political will and consistent prioritization.
Citations (18)
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “I will assess US pandemic preparedness by reviewing recent official reports, expert analyses, and key readiness indicators from public health agencies and independent evaluations.No, the United States is not fully prepared for another pandemic or widespread health crisis, though it has made meaningful improvements in…”
- https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “areas since COVID-19 while facing persistent gaps and recent setbacks that leave it vulnerable.”
- https://www.gao.gov/products/gao-24-107175
Backs: “workforce shortages, supply-chain risks, eroded public trust, and variable state/local readiness.”
- https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/
Backs: “Assessments from bipartisan commissions, the Government Accountability Office (GAO), Trust for America’s Health (TFAH), the World Health Organization (WHO) Joint External Evaluation (JEE), CDC testimony, and independent experts consistently show a mixed picture: enhanced stockpiles, surveillance tools, and medical…”
- https://www.who.int/publications/i/item/9789240105409
Backs: “Recent policy and funding disruptions (2025–2026) have further weakened capacity.[[3]](https://www.gao.gov/products/gao-24-”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “BARDA and related programs advanced vaccines, therapeutics, and diagnostics (including for mpox/smallpox and other threats), with ongoing deployments for H5N1 and other outbreaks. Domestic manufacturing capacity received investments, and “warm base” lab partnerships expanded testing surge potential.”
- https://www.aspr.gov/news-updates/blog/2025-12/stand-ready-move-fast-save-lives
Backs: “Domestic manufacturing capacity received investments, and “warm base” lab partnerships expanded testing surge potent”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “Surveillance and Data: Electronic case reporting grew dramatically (from under 200 healthcare facilities pre-COVID to over 45,000–48,000 by late 2024). Syndromic surveillance covers most hospital EDs.”
- https://www.presidency.ucsb.edu/documents/fact-sheet-biden-harris-administration-releases-global-health-security-annual-report
Backs: “National strategies (biodefense, global health security, health security) were updated. Global investments (e.g., Pandemic Fund contributions, vaccine sharing) aimed to reduce external threats.”
- https://www.presidency.ucsb.edu/documents/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response
Backs: “National strategies (biodefense, global health security, health security) were updated. Global investments (e.g., Pandemic Fund contributions, vacc”
- https://www.gao.gov/products/gao-23-106829
Backs: “The Bipartisan Commission on Biodefense’s 2024 National Blueprint states the nation “remains dangerously vulnerable,” calls for “immediate action,” and urges top-level White House leadership (e.g., codifying National Security Advisor roles) because efforts remain fragmented. Interagency exercises historically failed…”
- https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/
Backs: “Recent disruptions (grant cancellations, flat or reduced appropriations, workforce losses) have compounded this. ASPR’s multiyear budget estimates highlight large”
- https://www.aspr.gov/news-updates/newsroom/2026-07/PHEMCE-Multiyear-Budget-July2026
Backs: “ASPR’s multiyear budget estimates highlight large needs for threat-agnostic tech, manufacturing, and SNS sustainment.[[12]](https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framew”
- https://www.notus.org/health-science/white-house-pandemic-preparedness
Backs: “Funding freezes, grant cuts, shifts away from certain biodefense/emerging infectious disease research at NIAID/NIH, USAID restructuring impacts on global surveillance, and WHO withdrawal have been cited by experts as reducing readiness for spillover events, outbreaks (e.g., measles, Ebola, H5N1, parasites), and future…”
- https://www.tfah.org/article/new-report-chronic-underinvestment-and-recent-disruptions-have-weakened-u-s-public-health-system/
Backs: “Funding freezes, grant cuts, shifts away from certain biodefense/emerging infectious disease research at NIAID/NIH, USAID restructuring impacts on global surveillance, and WHO withdrawal have been cited by experts as reducing readiness for spillover events, outbreaks (e.g., measles, Ebola, H5N1, parasites), and future…”
- https://www.the-scientist.com/niaid-moves-away-from-biodefense-experts-are-worried-75109
Backs: “Analyses describe the system as weakened by chronic underinvestment plus acute disruptions.[[14]](https://www.notus.org/heal”
- https://www.nytimes.com/2026/09/26/health/cdc-staff-cuts-rfk-jr.html
Backs: “Analyses describe the system as weakened by chronic underinvestment plus acute disruptions.”
- https://www.nejm.org/doi/full/10.1056/NEJMp2406427
Backs: “has stronger baseline tools (stockpiles, digital surveillance, MCM pipelines, some coordination mechanisms) than in early 2020 and ranks relatively high historically on indices like the Global Health Security Index—yet COVID exposed that rankings do not guarantee effective real-world performance amid politics, trust…”